Clinical Trial Update: Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Concerta for ADHD in youth and adults with Bipolar Disorder. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Bipolar Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD, Bipolar Disorder | Phase 4 | Status: COMPLETED